Article
Chronic β2AR stimulation limits CFTR activation in human airway epithelia.
JCI insight - 22 Feb 2018
Brewington John J, Backstrom Jessica, Feldman Amanda, Kramer Elizabeth L, Moncivaiz Jessica D, Ostmann Alicia J, Zhu Xiaoting, Lu L Jason, Clancy John P
Abstract excerpt
Traditional pulmonary therapies for cystic fibrosis (CF) target the downstream effects of CF transmembrane conductance regulator (CFTR) dysfunction (the cause of CF). Use of one such therapy, β-adrenergic bronchodilators (such as albuterol), is nearly universal for airway clearance. Conversely, novel modulator therapies restore function to select mutant CFTR proteins, offering a disease-modifying treatment....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
